The Relapse of Cancer Stem Cells and the Importance of Their Biomarkers in Cancer Research

Katie Bender


Biomarkers have become a point of interest to scientific researchers in cancer stem cells when it comes to tumor relapse. Experiments have provided data of the probability of relapse by evaluating cancer stem cells in the tumor’s environment. Cancer stem cells are known to have a higher chance to relapse compared to regular cancer cells due to their resistance of radiation therapy. The biomarkers on cancers that are known for high mortality rates have been conducted in studies in the relativeness of treatment in cancer patients. Studies have concluded that cancer therapy may differ to each patient and perhaps may require a second kind of treatment based on the tumor’s characteristics.

Full Text:



  • There are currently no refbacks.